GLP-1 and Dual GIP/GLP-1 Receptor Agonists: From Science to Practice

Join leading experts in endocrinology, obesity medicine, and clinical pharmacology for a deep dive into the evolving landscape of GLP-1 and Dual GIP/GLP-1 receptor agonists.
This comprehensive two-day masterclass series will explore the past, present, and future of incretin-based therapies in the management of obesity, type 2 diabetes, and related comorbidities.